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Abstract. 
 
Crm1 is a member of the karyopherin family
of nucleocytoplasmic transport receptors and mediates
the export of proteins from the nucleus by forming a
ternary complex with cargo and Ran:GTP. This com-
plex translocates through the nuclear pores and dissoci-
ates in the cytosol. The yeast protein Yrb2p participates
in this pathway and binds Crm1, but its mechanism of
action has not been established. We show that the
human orthologue of Yrb2p, Ran-binding protein 3
(RanBP3), acts as a cofactor for Crm1-mediated export
in a permeabilized cell assay. RanBP3 binds directly to
Crm1, and the complex posseses an enhanced afﬁnity
for both Ran:GTP and cargo. RanBP3 shuttles between
the nucleus and the cytoplasm by a Crm1-dependent
mechanism, and the Crm1–RanBP3-NES-Ran:GTP
quarternary complex can associate with nucleoporins.
We infer that this complex translocates through the nu-
clear pore to the cytoplasm where it is disassembled by
RanBP1 and Ran GTPase–activating protein.
Key words: Crm1 • nuclear export • permeabilized
cells • Ran • RanBP3
 
Introduction
 
Eukaryotic cells are defined by the presence of a mem-
brane-bounded nucleus that separates transcription from
translation. Cells must transport many types of protein
and nucleic acids across the nuclear membrane. This cargo
moves through the nuclear pore complexes (NPCs)
 
1
 
,
which are macromolecular assemblies that penetrate the
nuclear double membrane, (for review see Davis, 1995).
The translocation of cargo is often facilitated by soluble
receptors that can bind NPCs and also recognize targeting
signals within the cargo (Gorlich, 1998; Mattaj and En-
glmeier, 1998; Pemberton et al., 1998; Nakielny and Drey-
fuss, 1999). These receptors have been variously termed
karyopherins, importins, exportins, and transportins. Al-
though possessing only limited sequence similarity, they
have the common property of binding to nuclear pore
components (nucleoporins) and to the small GTPase Ran.
Ran is predominantly nuclear at steady state (Bischoff
and Ponstingl, 1991). The guanine nucleotide exchange
factor for Ran (RanGEF) is confined within the nucleus
(Bischoff and Ponstingl, 1991), whereas a Ran GTPase–
activating protein (RanGAP) is located both in the cytosol
(Ohtsubo et al., 1989; Hopper et al., 1990; Bischoff et al.,
1994) and tethered to the external face of the NPC (Ma-
tunis et al., 1996; Mahajan et al., 1997; Saitoh et al., 1997).
The compartmentalization of these factors is believed to
create a steep gradient of Ran:GTP across the NPC, and
the asymmetric distribution of Ran:GTP is a major deter-
minant imparting directionality upon nuclear transport
(Gorlich, 1998; Mattaj and Englmeier, 1998; Pemberton et
al., 1998; Macara et al., 2000). Ran:GTP binds to the
karyopherin class of nuclear transport receptors and pro-
motes either the assembly or disassembly of receptor–
cargo complexes.
Nuclear protein export cargo is frequently identified by
a leucine-rich sequence termed a nuclear export signal
(NES). A leucine-rich NES has been identified in the
protein kinase A inhibitor (PKI) as well as RanBP1,
MAPKK, HIV Rev, and many other proteins (Wen et al.,
1995; Fukuda et al., 1996; Richards et al., 1996). The leu-
cine-rich NES is recognized by the karyopherin family
member, Crm1 (exportin-1 or Xpo1p in 
 
S
 
.
 
 cerevisiae
 
)
(Fornerod et al., 1997a; Fukuda et al., 1997; Ossarehnazari
et al., 1997; Stade et al., 1997). Within the nucleus, Crm1
can form a ternary complex with NES-containing cargoes
and Ran:GTP and translocate through the NPC. A re-
cently discovered cofactor, Nxt1, facilitates delivery of the
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export complex to the cytoplasmic side of the NPC, where
the complex docks on the nucleoporin CAN/Nup 214, un-
til it is released by association with RanGAP and RanBP1
(Askjaer et al., 1999; Black et al., 1999, 2001; Katahira et
al., 1999; Kehlenbach et al., 1999). These two factors to-
gether catalyze the hydrolysis of Ran:GTP to Ran:GDP.
Complex disassembly may precede GTP hydrolysis as the
latter is not strictly required for in vivo nuclear export
over short time periods (Richards et al., 1997). The un-
loaded Crm1 can presumably shuttle back through the
pore to complete the cycle.
Although the current model addresses the vectoriality
of nuclear export, it is likely that the actual process is con-
siderably more complex. For instance, the affinities of
many endogenous export cargoes for Crm1 are remark-
ably low even in the presence of Ran:GTP (Askjaer et al.,
1999; this study). The affinity of Crm1 for the HIV-1 pro-
tein, Rev, is increased substantially by eIF-5A (Hofmann
et al., 2001) but a similar effect has not been observed for
any endogenous cargo, so it remains unclear whether eIF-
5A normally functions as an export cofactor. Nonetheless,
we reasoned that additional cofactors may participate in
Crm1-mediated nuclear protein export to facilitate endog-
enous cargo loading.
Here, we show that Ran-binding protein 3 (RanBP3)
behaves as a cofactor for Crm1-mediated export. RanBP3
binds to Crm1, and the complex possesses a higher affinity
for Ran:GTP and for NES-containing cargo. We present
evidence that, after assembly in the nucleus, the Crm1–
RanBP3-Ran:GTP-NES cargo complex interacts with the
NPC. After translocation through the pore into the cyto-
plasm, this quarternary complex is disassembled via the
concerted action of RanBP1 and RanGAP.
 
Materials and Methods
 
DNA and Peptide Constructs
 
The cDNA encoding full-length RanBP3 was inserted in pGEX-2T1 (Am-
ersham Pharmacia Biotech) and pKH3 vectors (Welch et al., 1999).
RanBP3 deletions were created by PCR amplification of the indicated do-
mains and ligation into pGEX-2T1. pQE60-Crm1 was a gift from Iain
Mattaj (EMBL, Heidelberg, Germany), pQE30-RanQ69L from Dirk
Görlich (University of Heidelberg, Heidelberg, Germany), and p62
cDNA from John Hanover (National Institutes of Health, Bethesda,
MD). All constructs were checked by automated sequencing. Peptides
used in binding and GAP assays: MVM NS2 NES peptide, CVDEMT-
KKFGTLTIHDTEK (Askjaer et al., 1999); PKI NES peptide, GSNELA-
LKLAGLDINKTGGC (Holaska and Paschal, 1998); and as a control
peptide, CGAGRSSMAHGPGA.
 
Protein Expression and Purification
 
Glutathione 
 
S
 
-transferase (GST) fusion proteins were expressed in 
 
Esch-
erichia coli
 
 XL1-Blue as described previously (Lounsbury and Macara,
1997; Welch et al., 1999). Proteins were bound to glutathione–Sepharose
beads (Amersham Pharmacia Biotech), eluted with glutathione, and ex-
changed into thrombin cleavage buffer (50 mM Tris, pH 7.5, 150 mM
NaCl, and 2.5 mM CaCl
 
2
 
) using a PD10 column (Amersham Pharmacia
Biotech) (Nemergut and Macara, 2000). Proteins were cleaved with
thrombin, and GST and thrombin were removed with glutathione–
Sepharose and p-aminobenzamidine beads (Sigma-Aldrich), respectively.
His-tagged RanQ69L and Crm1-His
 
6
 
 were expressed and purified on
Talon beads (CLONTECH Laboratories, Inc.), as described previously
(Askjaer et al., 1999). Addition of 28 mM 2-mercaptoethanol was re-
quired to insure recovery of functional Crm1 protein. Proteins were con-
centrated using a Centricon 30 (Amicon).
 
Protein Binding Assays
 
GST fusion proteins were bound to glutathione–Sepharose beads in 3%
BSA/PBS for 1 h at 4
 
 
 
C. Beads were washed 2
 
 
 
 with buffer A (20 mM
Hepes, pH 7.4, 150 mM KOAc, 2 mM MgOAc, 0.1% Tween 20, 28 mM
 
 
 
-ME, 0.1% BSA) and then added to solutions containing combinations of
transport factors preassembled in this buffer. After incubation with shak-
ing (1 h at 4
 
 
 
C), the beads (10 
 
 
 
l) were washed 4
 
 
 
 with 1.0 ml buffer A
without BSA, subjected to SDS-PAGE, and analyzed by immunoblotting.
Proteins were detected with monoclonal antibodies against the His
 
6
 
 tag
(1:2,000; Babco), GST (gift of T. Parsons, University of Virginia, Char-
lottesville, VA; 1:10,000), Ran (1:1,800; Transduction Laboratories),
Nup214 (RL-1, 1:1,000), p62 (1:1,000; Transduction Laboratories) or poly-
clonal antibodies against Crm1 (gift of L. Gerace, The Scripps Research
Institute, La Jolla, CA; 1:10,000), or polyclonal antibodies against
RanBP1 (1:200; Santa Cruz Biotechnology, Inc.), followed by HRP-conju-
gated secondary antibodies (1:20,000; The Jackson Laboratory) and expo-
sure to a chemiluminescence reagent (KPL). Quantitation of immunoblot-
ting was performed with a densitometer (Molecular Dynamics); and
analysis, with ImageQuant v3.3 software (Molecular Dynamics).
Peptides were conjugated to Sulfolink
 
®
 
 beads (Pierce Chemical Co.)
according to the manufacturer’s instructions. Beads were blocked in 3%
BSA/PBS (1 h at 4
 
 
 
C) and then washed 2
 
 
 
 with buffer B (20 mM Hepes,
pH 7.4, 150 mM NaCl, 2 mM MgOAc, 0.1% Tween 20, 28 mM 
 
 
 
-ME,
0.1% BSA) and shaken for 2 h at 4
 
 
 
C with transport factors preassembled
in binding buffer. After washing with buffer B (substituted with 300 mM
NaCl), the beads were analyzed as described above.
Binding reactions on Ni
 
2
 
 
 
-NTA beads (QIAGEN) were performed
with buffer C (20 mM Hepes, pH 7.4, 300 mM NaCl, 6 mM MgOAc, 0.1%
Tween 20, 14 mM 
 
 
 
-ME, 2% BSA, 10 mM imidazole). After loading with
Crm1-H
 
6
 
 in buffer C without imidazole, beads were aliquoted and exposed
to transport factors for 1 h at 4
 
 
 
C. The beads were then resuspended in
buffer C and drawn into preblocked Wizard minicolumns (Promega), and
washed 2
 
 
 
 with 3 ml of buffer C before scintillation counting.
ELISA assays were performed as described previously (Harlow and
Lane, 1999). In brief, Crm1 was immobilized on polystyrene 96-well plates.
After blocking with 3% BSA/0.1% Tween 20/PBS, the wells were exposed
to dilutions of GST-RanBP3 containing RanQ69L, RanQ69L, and NES,
or buffer alone, for 1 h in buffer A. After washing, GST was identified
with anti-GST monoclonal antibody (1:20,000), followed by anti–mouse
HRP-conjugated antibody (1:4,000). After exposure to 3,3
 
 
 
,5,5
 
 
 
-tetrameth-
ylbenzidine (Sigma-Aldrich) for 10 min, the solution was acidified with
0.5 M H
 
2
 
SO
 
4 
 
and read at 410 nM on a EL
 
X
 
-800 plate reader (Bio-Tek In-
struments). Binding data were fit by an iterative procedure to an equation
describing a single binding site: fractional saturation, 
 
f
 
 
 
  
 
x
 
/(
 
K
 
app 
 
  
 
x
 
)
(where 
 
x
 
    
 
Crm1 for immunoblotting and GST-RanBP3 for ELISA).
Analysis was performed using Kaleidagraph v3.5 (Synergy Software).
Nucleoporin immunoprecipitations were performed as described
(Kehlenbach et al., 1999) and supplemented with Crm1 (50 nM), RanBP3
(200 nM), RanQ69L (2 
 
 
 
M), and/or MVM NS2 NES peptide (4 
 
 
 
M).
 
Yeast Dihybrid Analysis
 
Bait plasmids encoding fusion proteins of the DNA-binding domain of
Gal4p and human importin 11, CAS, importin-
 
 
 
, or Crm1 were trans-
formed into a HF7c yeast strain. HF7c yeast possess a 
 
HIS3
 
 gene driven
by the Gal1 promoter allowing for Gal4 fusion protein–dependent histi-
dine prototrophy. The yeast were mated with W303
 
 
 
 strains harboring fu-
sion proteins of the VP16 activation domain and Ran or RanBP3 or vector
alone, and then replica plated onto L
 
 
 
H
 
 
 
W
 
 
 
 drop-out medium to select
for bait–prey interactions (Plafker and Macara, 2000b).
 
Heterokaryon Fusion Assays and Nucleoporin 
Binding Assays
 
Fusion assays were performed as described previously (Plafker and Ma-
cara, 2000b). Baby hamster kidney (BHK21) cells were transfected by the
CaPO
 
4
 
 method (Sambrook et al., 1989). After 24 h, these donor cells were
trypsinized, mixed with GSN2 acceptor cells, and replated on poly-
 
L
 
-lysine–coated coverslips. GSN2 cells are stably transfected cells that ex-
press a green fluorescent protein (GFP)–streptavidin–nuclear localization
signal (NLS) fusion protein (Black et al., 1999). At 48 h, the cells were
fused by the addition of 40% PEG 3500 in HBSS for 2 min at 37
 
 
 
C. The
cells were washed with HBSS and incubated for 1 h in DME 5% FCS/5%
CS plus 35.5 
 
 
 
M cycloheximide. Where indicated, leptomycin B (LMB) 
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was added to the media (200 nM). The cells were fixed with 4% (wt/vol)
paraformaldehyde (PFA)/PBS, permeabilized with 
 
 
 
20
 
 
 
C methanol, and
blocked in 3% BSA/PBS.
Nuclear envelope–binding assays were performed essentially as de-
scribed (Gorlich et al., 1995; Kutay et al., 1997). In brief, factors were as-
sembled in transport buffer (20 mM Hepes-KOH, pH 7.4, 110 mM KOAc,
2 mM MgOAc, 0.5 mM EGTA) before incubation with digitonin-perme-
abilized BHK21 cells for 30 min at 24
 
 
 
C. After washing, nuclei were fixed
and blocked in 3% BSA/PBS. HA-tagged proteins were detected with
12CA5 monoclonal antibody (1:2,000), Crm1 with a rabbit polyclonal an-
tibody (1:1,000), GST-RanBP3 with a monoclonal anti-GST antibody
(1:1,000), and Texas red–conjugated secondary antibodies (1:5,000; Mo-
lecular Probes). Nuclei were stained with DAPI. Coverslips were
mounted on glass slides with Gel Mount (Biomedia). Cells were visualized
by fluorescence microscopy using a Nikon microscope with a 60
 
 
 
 water
immersion lens. Images were captured with a Hamamatsu charge-coupled
device camera and quantified with Openlab software (Improvision).
 
RanGAP Assays
 
RanGAP protection assays were performed as described (Askjaer et al.,
1999). In brief, Ran was loaded with 
 
 
 
[
 
32
 
P]GTP (Lounsbury and Macara,
1997) and added to Crm1 (330 nM), 
 
 
 
NES peptide (0–20 
 
 
 
M), and
 
 
 
RanBP3 (1 
 
 
 
M) in 40 
 
 
 
l reaction buffer (36 mM Tris-HCl, pH 8.0, 75
mM NaCl, 6 mM MgCl
 
2
 
, 0.8 mM dithiothreitol, 0.5 mM GTP, 0.1 mg BSA/
ml, 1 mM NaPO
 
4
 
, and 1% glycerol) for 20 min on ice. Diluted GST-Ran-
GAP was added to the complexes at 34
 
 
 
C for 4 min. The reaction mixes
were passed through nitrocellulose filters and washed. Ran:
 
 
 
[
 
32
 
P]GTP
was quantitated by scintillation counting. Values are expressed as the per-
centage of counts bound after incubation of Ran without RanGAP.
 
In Vitro Protein Export Assay
 
Nuclear export assays were performed as described previously with
RanBP3 construct supplemented in the 8-min export phase (Holaska and
Paschal, 1998). Recombinant proteins used were produced as described
above. Quantitative data represent a minimum of 40–50 cells per reaction.
 
Results
 
RanBP3 Stimulates Crm1-mediated 
Nuclear Protein Export
 
Genetic and biochemical evidence has linked the yeast
orthologue of RanBP3, Yrb2p, to Xpo1p-dependent nu-
clear protein export, but the function of Yrb2p in export
remains unknown (Taura et al., 1998; Noguchi et al.,
1999). To test whether RanBP3 is involved in Crm1-medi-
ated nuclear export, we used an in vitro nuclear export as-
say that uses the NES of PKI (Holaska and Paschal, 1998).
This two-step assay involves an import and an export
phase. In the import phase, a fluorescein isothiocyanate–
conjugated streptavidin–NLS fusion protein (FITC–STV–
NLS) is imported into nuclei of digitonin-permeabilized
HeLa cells with lysate. In the export phase, biotinylated
PKI (bPKI) is added, which is small enough to diffuse into
the nucleus. There it can bind the fluorescent streptavidin
and, in the presence of soluble transport factors, mediate
export of bPKI/FITC–STV–NLS into the cytoplasm. Re-
sidual nuclear fluorescence is quantitated, and export ac-
tivity is measured as the loss of fluorescence compared
with controls that lack the necessary transport factors.
To seek an effect of RanBP3 on nuclear protein export,
it was necessary to find levels of Crm1 and Ran that were
limiting with respect to export activity. A limiting concen-
tration of Crm1 (90 nM) alone or Crm1 plus Ran (1.0 
 
 
 
M)
did not significantly increase the amount of export over
buffer alone (Fig. 1, A and B). However, when this
amount of Crm1 and Ran was supplemented with GST-
RanBP3 (1.0 
 
 
 
M), a significant loss of nuclear fluores-
cence was measured. This activity was fully inhibited by
the addition of LMB, which reacts covalently with Crm1
and inhibits its interaction with NES cargo (Kudo et al.,
1999). RanBP3 lacking the GST tag also activated ex-
port (data not shown). Therefore, RanBP3 can stimulate
Crm1-dependent export activity in a permeabilized cell
nuclear export assay.
 
RanBP3 Binds Directly and Specifically to Crm1
 
Next, we asked whether a direct association could be ob-
served between RanBP3 and Crm1. As shown in Fig. 2
A, His-tagged Crm1 (Crm1-H
 
6
 
) associated with GST-
RanBP3 directly (lane 8). RanQ69L, a GTPase-deficient
Ran mutant, was efficiently incorporated into the Crm1–
RanBP3 complex without reducing the levels of bound
Crm1 (lanes 8 and 9). These data suggest that Crm1,
RanBP3, and Ran can form a stable ternary complex.
Crm1 has been shown to form ternary complexes with
Ran:GTP and NES-bearing proteins. We predicted that
RanBP3 was not acting as a classic NES, because it could
enhance Crm1-mediated export in vitro (Fig. 1) and its
binding to Crm1 was not enhanced by Ran. Nevertheless,
to determine whether binding of RanBP3 to Crm1 was
competitive with NES binding, we analyzed the Crm1–
RanBP3 interaction in the presence of a large molar ex-
cess of a NES peptide. Neither NES peptide alone nor
NES peptide plus RanQ69L prevented Crm1 from binding
GST-RanBP3 (Fig. 2 A, lanes 10 and 11). Moreover, LMB
did not inhibit binding of Crm1 or RanQ69L to GST-
RanBP3 (lane 12), although it completely inhibited Crm1
binding to NES (Fig. 3 A). Together, these data demon-
strate that the interaction between Crm1 and RanBP3 is
distinct from that between Crm1 and NES.
To assess the selectivity of this interaction, the binding
of RanBP3 to other karyopherin-
 
 
 
 family members was
assayed in a yeast dihybrid assay. Only strains harboring
Crm1 and RanBP3 were able to support growth in the ab-
sence of histidine (Fig. 2 B). Importin-11, CAS, and im-
portin-
 
 
 
 were functional in this assay as they were able to
interact with VP16-Ran. The poor ability of Crm1 to inter-
act with Ran in this assay has been reported by others
(Stade et al., 1997). These data suggest that RanBP3 may
be a specific partner of Crm1.
 
RanBP3 Increases Crm1 Binding 
to Ran:GTP and Export Cargo
 
Can Crm1 within a RanBP3–Crm1–Ran:GTP complex still
bind NES cargo? To address this question, we used beads
coupled to an MVM-NS2 NES peptide. These beads were
exposed to solutions containing combinations of transport
factors (Fig. 3 A). Neither GST-RanBP3 nor RanQ69L
alone bound significantly to the beads without Crm1 (Fig.
3 A, lane 4), nor did any of these factors bind to control
beads generated from an unrelated peptide encoding an
NH
 
2
 
-terminal sequence from the small GTPase TC10 (Fig.
3 A, lanes 1–3). As expected from previous work, the NES
beads associated weakly with Crm1 alone, and RanQ69L
substantially increased the binding efficiency, reflecting
the increased affinity of Crm1 for NES in the presence of
Ran:GTP (Fig. 3 A, lane 5 vs. 6) (Fornerod et al., 1997a). 
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When GST-RanBP3 was added to the assay, a small
amount bound to Crm1 on the NES beads in the absence
of RanQ69L (lane 7). The amount of bound GST-RanBP3
increased when RanQ69L was included (Fig. 3 A, lane 8),
most likely reflecting the increased amount of Crm1 bound
to the beads. Addition of LMB to the assay abrogated the
ability of this complex to bind the beads (Fig. 3 A, lane 9).
Therefore, RanBP3 is able to bind in a quarternary com-
plex containing Crm1, RanBP3, NES, and Ran:GTP.
To more quantitatively determine the interaction of
Ran:GTP within this complex, we immobilized Crm1-H
 
6
 
on Ni
 
2
 
 
 
-NTA beads. The beads were then exposed to a ti-
tration of Ran:
 
 
 
[
 
32
 
P]GTP in the absence or presence of
GST-RanBP3 (4:1 molar ratio of RanBP3 to Crm1). The
titration was repeated with three levels of NES peptide: a
saturating level (40 
 
 
 
M), an intermediate level (100 nM),
or no peptide. At the lower levels of NES peptide (100 or
0 nM), RanBP3 significantly increased the amounts of
Ran:GTP bound within the complex (Fig. 3 B). These re-
sults indicate that, at subsaturating levels of NES, the af-
finity of the Crm1–RanBP3 complex for Ran:GTP is
greater than that of Crm1 alone. At very high NES con-
centration (40 
 
 
 
M), the binding of Ran:
 
 
 
[
 
32
 
P]GTP to
Crm1 was saturable in both the presence and absence of
RanBP3. Interestingly, although RanBP3 and Crm1 both
contain a Ran-binding domain (RBD), the amount of Ran
associated with Crm1 under saturating conditions was
identical in either the presence or absence of RanBP3.
This experiment indicates that the stoichiometry of Ran:
GTP with respect to Crm1 is not increased by binding to
RanBP3 and implies that RanBP3 acts by increasing the
affinity of the Crm1–RanBP3 complex for Ran:GTP,
rather than by independently binding a second Ran:GTP
per complex.
It is important to note that the relative concentrations of
RanBP3 and Crm1 are critical to the modulation of Ran’s
binding to Crm1. At low RanBP3:Crm1 ratios, such as the
one used above (4:1), RanBP3 increases the amount of
Ran:GTP bound to Crm1. However, when this ratio is in-
creased to 40:1, RanBP3 is unable to increase the amount
of Ran:GTP associated with the Crm1 beads (Fig. 3 C).
This behavior is predicted from the nature of the Crm1–
RanBP3–Ran:GTP complex. A large excess of free
RanBP3 is able to compete for available Ran:GTP with
the Crm1–RanBP3 complexes present on the beads. The
ability to stimulate Ran:GTP binding is dependent on the
presence of the RBD of RanBP3, as a mutant that lacks
this domain (NF; see below) was unable to mediate the ef-
fect (Fig. 3 C).
 
RanBP3 Increases the Affinity of Crm1 for NESs
 
To determine the effect of RanBP3 on the binding of cargo
to Crm1, we performed RanGAP protection assays. How-
ever, in light of the previously reported ability of Yrb2p to
weakly coactivate RanGAP (Noguchi et al., 1997), we first
tested whether RanBP3 had a similar biochemical activity.
Using a low concentration of RanGAP (150 pM) such that
only 
 
 
 
25% of the total Ran-bound 
 
 
 
[
 
32
 
P]GTP was hydro-
lyzed within the time frame of the assay, we observed that
RanBP3 has a weak ability to coactivate RanGAP in the
absence of other factors (Fig. 4 A). However, when Crm1
and NES were added to the assay, Ran was protected from
the action of RanGAP (data not shown).
The ability of the quaternary complex to protect Ran
from the action of RanGAP allowed us to assess quantita-
tively the interaction of Ran and NES with Crm1. The ad-
vantage of the GAP protection assay over the direct bind-
Figure 1. RanBP3 stimu-
lates Crm1-mediated nu-
clear protein export. (A)
Permeabilized HeLa cells
were preloaded with bPKI/
FITC–STV–NLS export
cargo and then exposed to
Crm1 (90 nM), Ran (1.0  M),
 RanBP3 (1.0  M),  LMB
(200 nM), as shown. Export
activity was monitored as a
loss of nuclear fluorescence
over 8 min at 30 C. (B)
Quantitation of PKI export.
Nuclear fluorescence was
measured for  50 randomly
chosen cells in each sample
and expressed as the mean  
1 SD. Results are representa-
tive of two independent ex-
periments. Bar, 10  m. 
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ing measurements shown in Fig. 3 is that the GAP assay is
performed in solution, under pseudoequilibrium condi-
tions, whereas bead binding assays involve repeated wash-
ing and are not at equilibrium. RanGAP was increased (to
30 nM) to insure complete hydrolysis of free Ran:GTP
during the assay. Crm1 alone has a low affinity for Ran:
GTP and as expected was unable to protect Ran from the
action of RanGAP (Fig. 4 B). However, when RanBP3 or
the NES from MVM-NS2 were added to the solution, 
 
 
 
25
and 
 
 
 
63% of the Ran:GTP were protected, respectively.
This result indicates that both RanBP3 and NES are able
individually to increase the affinity of Crm1 with Ran:
GTP. When both RanBP3 and NES were added, the pro-
tection was additive, such that 
 
 
 
85% of the GTP re-
mained. Therefore, the formation of a quaternary complex
described above (Fig. 3 A) can also be detected in this as-
say. The effect was not specific to this particular NES, as
the increased protection was also observed with the NES
from PKI (Fig. 4 B), however to a lesser extent due to the
lower affinity of PKI NES versus the MVM NS2 NES for
Crm1 (Askjaer et al., 1999).
The fact that NES cargo binds cooperatively with Ran:
GTP to Crm1, and that RanBP3 raises the affinity of Crm1
for Ran:GTP (Fig. 3 B), argues that RanBP3 should also
 
increase the affinity of Crm1 for NES cargo. To test this
idea, we titrated the RanGAP protection by the MVM-
NS2 NES in the absence and presence of RanBP3. In-
creasing the concentration of NES increased the protec-
tion from RanGAP, in a saturable manner (Fig. 4 C), and
RanBP3 was able to increase the affinity of Crm1 for the
MVM-NS2 NES by 1.6-fold (from 
 
K
 
app
 
 
 
  
 
540–330 nM).
These data indicate that RanBP3 and NES are both able
to facilitate Ran:GTP binding to Crm1 complexes, but by
independent mechanisms. RanBP3 also increases the af-
finity of Crm1 for NES cargo, but this property seems to
be dependent on Ran binding because RanBP3 did not al-
Figure 2. Crm1 binds directly and specifically to RanBP3. (A)
Crm1 binds directly to RanBP3 in the presence of RanQ69L and
NES peptide. Recombinant Crm1-H6 (200 nM) was incubated
with GST-tagged RanBP3 attached to glutathione–Sepharose
beads in the presence of RanQ69L (2  M), MVM NES peptide
(2  M), or LMB (2  M), as shown, and bound protein was ana-
lyzed by immunoblotting. (B) Yeast dihybrid conjugation assays.
S. cerevisiae HF7c (MAT-a) that express bait (GAL4DBD) fu-
sions of importin-11, Cas, importin , and Crm1 were mated to S.
cerevisiae W303 (MAT- ) that express the VP16 activation do-
main alone or as prey fusions with Ran or RanBP3. Growth of
diploids is shown after replica plating to L H W  plates, which
support growth only of those yeast in which the bait fusion inter-
acts with the prey fusion protein. Figure 3. RanBP3 increases the affinity of Crm1 for Ran:GTP.
(A) Various combinations of Crm1-H6 (330 nM), GST-RanBP3
(250 nM), and RanQ69L (2.0  M) were incubated with MVM NS2
NES peptide–conjugated beads (5  l). Bound and unbound frac-
tions were analyzed by anti-His6 (Crm1), anti-Ran (RanQ69L),
and anti-GST (GST-RanBP3) immunoblotting. The detected spe-
cies are indicated at right. (B) Wild-type Ran was loaded with
 [32P]GTP and incubated with immobilized Crm1-H6 (16 pmol) on
Ni2 -NTA beads in the absence or presence of GST-RanBP3 (120
nM) or MVM-NS2 NES peptide (0, 100, or 4,000 nM). After wash-
ing, bound Ran [32P]GTP was counted and graphed as percent
maximal binding. (C) Assay was repeated as in B, with either
GST-RanBP3 or GST-NF mutant added at indicated molar ratios.
Values reported as average of three samples   SD.The Journal of Cell Biology, Volume 153, 2001 1396
ter the efficiency of Crm1 association with NES–peptide
beads in the absence of Ran (Fig. 3 A). Therefore, within
the nucleus, RanBP3 acts to increase the efficiency of
Crm1-mediated export by increasing the affinity of the
Crm1–RanBP3 complex for Ran:GTP, which coopera-
tively promotes cargo binding.
The FxFG Domain and RBD of RanBP3 Are Both 
Required for Efficient Crm1-mediated Export
To better understand the mechanism by which RanBP3
activates Crm1-dependent export, we generated various
RanBP3 mutants (Fig. 5 A). The N domain (residues
1–182) contains an NLS; the F domain (residues 183–293)
comprises the central region containing two FxFG motifs;
the R domain (residues 294–499) comprises the COOH-ter-
minal low-affinity Ran:GTP-binding domain (Radu et al.,
1995; Mueller et al., 1998; Welch et al., 1999). Interestingly,
we found that RanBP3 possesses two distinct direct binding
sites for Crm1 (Fig. 5 B). The major binding site is located
in the F domain. A weaker binding site resides in the N do-
main. No binding was detected using the isolated R domain.
To determine which domains of the RanBP3 protein are
responsible for export activity, the export assay was re-
peated using the recombinant F, R, FR, and NF fragments.
Only FR, comprising both the F and R domain, restored
full export activity (Fig. 5 C). Remarkably, the F fragment
alone had an intermediate activity. However, this activity
was suppressed by the presence of the NH2-terminal re-
gion, as the NF fragment had no detectable activity. It has
been shown that RanBP1 can also stimulate Crm1-medi-
ated export, by dissociating Crm1 from nuclear pores
(Kehlenbach et al., 1999). However, it is unlikely that
RanBP3 operates via this mechanism, for two reasons.
First, the RanBP1 effect on nuclear export is apparent only
after preincubation of the cells with RanQ69L (Kehlenbach
et al., 1999); second, the R fragment, which contains the
RanBP1-like domain, has no activity in this assay (Fig. 5 C).
To determine whether the export activity correlated
with the ability of RanBP3 to promote Ran:GTP binding
to Crm1, we repeated the RanGAP protection assay with
the deletion mutants. As shown in Fig. 5 D, the ability of
RanBP3 to promote Ran:GTP binding to Crm1 is depen-
dent on both the F and R domains of RanBP3, matching
the requirement for full export activity. Note that the
RBD, R, is unable in isolation to promote Ran binding to
Crm1, probably because it has a very low intrinsic affinity
for Ran:GTP (Mueller et al., 1998).
Together, these data demonstrate that the stimulation of
export by RanBP3 requires its major site for Crm1 bind-
ing, the F domain, with maximal activity requiring both
the F and R domains.
RanBP3 Exports from the Nucleus
in a Crm1-dependent Manner
What is the fate of the Crm1–RanBP3-NES-Ran:GTP
complex once it has assembled within the nucleus? We
considered two alternate hypotheses. First, the quarternary
complex could exit the nucleus as a unit. Second, RanBP3
could act as an assembly catalyst and be removed from the
complex before export. The first model predicts that
Figure 4. RanBP3 in-
creases the affinity of Crm1
for Ran:GTP and NES. (A)
RanBP3 is a weak coactiva-
tor of RanGAP. GST-Ran-
GAP (0.15 nM) was added
to preassembled complexes
of Ran [32P]GTP (40 nM)
 RanBP3 (1 or 10  M) for 4
min at 30 C. After filter bind-
ing to nitrocellulose, protein-
associated Ran [32P]GTP
was detected by scintillation
counting. (B) RanBP3 in-
creases Crm1-mediated pro-
tection of Ran:GTP from
RanGAP. GST-RanGAP
(30 nM) was added to pre-
assembled complexes of
Ran [32P]GTP (40 nM),
cleaved RanBP3 (1  M),
Crm1-H6 (330 nM), and NES
peptide (200 nM). (C)
RanBP3 increases the Crm1
affinity for NES. Titration of
Crm1 and Ran [32P]GTP
with an increasing concentra-
tion of NES peptide (0–20
 M) was performed in the
presence ( ) or absence ( )
of RanBP3 (1  M).Lindsay et al. RanBP3 Is a Crm1-dependent Export Factor 1397
RanBP3 cycles in and out of the nucleus, whereas the sec-
ond model predicts that it is constitutively nuclear. To dis-
tinguish between these models, heterokaryon fusion assays
were performed, to test the ability of RanBP3 to shuttle.
For this assay, we used a triple hemagglutinin–tagged
RanBP3 (HA3-RanBP3) (Welch et al., 1999). After trans-
fection of BHK21 cells, they were trypsinized and replated
with an equal number of GSN2 cells, which express a
GFP–streptavidin–NLS fusion protein as a non-shuttling
nuclear marker (Black et al., 1999). The two cell types
were fused, fixed, and stained. HA3-RanBP3 shuttled from
BHK21 nuclei into GSN2 nuclei, as evidenced by the co-
staining of the GSN2 nuclei (Fig. 6 A). The GFP–strepta-
vidin–NLS fusion protein remained within the GSN2 ac-
ceptor nucleus. We conclude that RanBP3 is a shuttling
protein and, in principle, could be exported as a compo-
nent of a Crm1–RanBP3–NES–Ran:GTP complex.
If this hypothesis were correct, RanBP3 export should
be Crm1 dependent. To test this prediction, we used the
Crm1-specific inhibitor, LMB. Heterokaryon fusion assays
were performed with HA3-RanBP3 and, as a control, with
GFP–GFP–RanBP1 (GGRanBP1). RanBP1 is a shuttling
protein that contains a LMB-sensitive NES (Richards et
al., 1996; Plafker and Macara, 2000a). The additional size
imparted by the two GFPs prevents passive diffusion of
the protein through the nuclear pores. Therefore, upon
the addition of LMB, this construct accumulates irrevers-
ibly in the nucleus (Plafker and Macara, 2000a).
HA3-RanBP3 and GGRanBP1 were cotransfected into
BHK21 cells that were plated at high density. Adjacent
cells were fused, and their cytoplasms were allowed to
mix. As expected, GGRanBP1 was cytoplasmic, whereas
HA3-RanBP3 was nuclear (Fig. 6 B). When LMB was
added after fusion, GGRanBP1 translocated into all of the
nuclei of the multikaryon cell. However, when LMB was
added before fusion, GGRanBP1 is present only in the do-
nor nuclei, demonstrating that LMB completely prevents
the export of a Crm1-dependent cargo. Under these condi-
tions, RanBP3 is unable to shuttle (Fig. 6 B), indicating
that export of RanBP3 is LMB sensitive. These data dem-
onstrate that export of RanBP3 is dependent on formation
of productive Crm1 export complexes.
The Crm1–RanBP3–NES–Ran:GTP 
Complex Interacts with NPCs
Since RanBP3 export was Crm1 dependent, we hypothe-
sized that the Crm1–RanBP3–NES–Ran:GTP complex
could interact with nucleoporins. To test this hypothesis,
we first asked if RanBP3 could compete for Crm1 binding
to nucleoporins. Cells were permeabilized with digitonin,
washed to remove soluble components, and then solubi-
lized with 1% NP-40 (Kehlenbach et al., 1999). The solu-
ble extract, enriched in nucleoporins, was incubated with
Crm1 and/or RanBP3, RanQ69L, and NES peptide. Crm1
was precipitated with anti-Crm1 antibodies, and associ-
ated proteins were detected by immunoblotting. When
supplemented with RanQ69L or RanQ69L and NES
peptide, Crm1 bound both Nup214 and p62 (Fig. 7 A),
as reported previously (Kehlenbach et al., 1999). When
RanBP3 was added in large excess, it did not reduce nu-
cleoporin binding, suggesting that RanBP3 does not compete
with Nup214 or p62 for Crm1 in the presence of Ran:GTP.
Figure 5. The FxFG-containing domain and RBD of RanBP3
are required for full export activity. (A) Diagram of deletion mu-
tants, showing domain structure of RanBP3. Mutants are illus-
trated without the 27-kD amino terminal GST tag. Locations of
the NLS, two FxFG repeats, and the RBD are indicated. (B)
Crm1-H6 was exposed to glutathione–Sepharose beads coated
with various GST-tagged RanBP3 fragments. Unbound protein
was identified by Coomassie brilliant blue (CBB) staining. Bound
protein was identified by both Coomassie staining and immuno-
blotting with an anti-His6 antibody. (C) Deletion mapping of Crm1-
dependent export activity. The PKI export assay was performed
as described in the legend to Fig. 1, using 100  g/ml of each GST-
RanBP3 fragment. Nuclear fluorescence was quantitated in  50
randomly chosen cells for each experimental condition and is pre-
sented as the mean   SD. Export activity is represented as loss of
fluorescence. (D) The RanGAP protection assay was repeated as
described in the legend to Fig. 4 with equimolar levels of GST-
RanBP3 deletion mutants.The Journal of Cell Biology, Volume 153, 2001 1398
This result was of interest because the F domain contains
FxFG motifs that are both representative of nucleoporins
and have been shown to directly bind to transport recep-
tors (Radu et al., 1995; Bayliss et al., 2000). Moreover, the
F domain is a principal Crm1 binding site on RanBP3.
To determine whether nucleoporins can bind to a
Crm1–RanBP3 complex, we used GST-RanBP3 on glu-
tathione–Sepharose beads. In the absence of Crm1, very
little Nup214 associated with the beads, suggesting that
RanBP3 alone does not bind with high affinity to this nu-
cleoporin. Similarly, when Crm1 was added, it bound
RanBP3 without increasing Nup214 binding. However,
addition of Crm1 and RanQ69L significantly increased
Nup214 binding to the beads. Binding did not occur to
beads coupled to GST alone (not shown). These results
suggest that RanBP3 and Nup214 can bind simultaneously
to Crm1, and this interaction is stabilized by Ran:GTP.
Detergent solubilization destroys the integrity of the
NPC, and may obscure low affinity interactions with nu-
cleoporins. We therefore tested the ability of Crm1 to bind
intact NPCs in the presence of various transport factors
(Fig. 7, C and D) (Fornerod et al., 1997b; Kehlenbach et
al., 1999). In the absence of RanBP3, binding of Crm1 to
NPCs was readily detectable under all conditions (Kehlen-
bach et al., 1999) (Fig. 7 C, top). Unexpectedly, RanBP3
inhibited the association of Crm1 with NPCs, and this inhi-
bition was relieved by addition of RanQ69L with or with-
out NES peptide. Conversely, RanBP3 was found to asso-
ciate with NPCs only in the presence of RanQ69L or
RanQ69L and NES peptide (Fig. 7 C, bottom). These data
suggest that Ran:GTP stimulates binding of the Crm1–
RanBP3 complex to NPCs.
To test this hypothesis, we studied the binding of LMB-
treated Crm1 to NPCs. In addition to preventing Crm1 from
binding to NES-containing proteins, it also prevents high-
affinity binding of Crm1 to Ran:GTP (Fornerod et al.,
1997a). Since RanBP3 can bind LMB-treated Crm1 (Fig. 2
A), RanBP3 should inhibit binding of LMB-treated Crm1 to
NPCs even in the presence of RanQ69L or RanQ69L and
NES peptide. This effect was observed (Fig. 7 C, bottom,
and D), demonstrating that high-affinity Ran binding to
Crm1 stimulates the Crm1–RanBP3 complex to bind NPCs.
How might Ran:GTP modulate the binding of the
Crm1–RanBP3 complex to the NPC? One interesting pos-
sibility is that Ran might alter the conformation of Crm1
such that it interacts with RanBP3 in a different manner,
exposing a surface on Crm1 involved in NPC binding. To
study the Crm1–RanBP3 interaction further, we first de-
termined its affinity by ELISA and quantitative immuno-
blotting. Each of these methods produced nearly identical
values (data not shown). By ELISA, the apparent dissoci-
ation constant of the RanBP3-Crm1 complex was 64   14
nM; this affinity was reduced only slightly by Ran:GTP
and NES (106   23 nM) (data not shown). A control pep-
tide that does not bind Crm1 (Fig. 3 A) does not mediate
this reduction. The cause of this change in affinity became
evident when we tested the effect of Ran:GTP on binding
of Crm1 to isolated domains of RanBP3. Ran:GTP plus
NES substantially reduced binding of the F domain of
RanBP3 to Crm1, although it increased binding of the R
domain (Fig. 7 E). Together, these data suggest that, in the
absence of Ran:GTP and NES, RanBP3 binds to Crm1
principally through the N and F domains, whereas in the
presence of Ran:GTP and NES, the interaction occurs pri-
marily through the N and R domains. Therefore, although
the affinity of full length RanBP3 for Crm1 does not
change substantially, there is a significant change in the
mode of binding. This change in binding mode could ex-
plain how Ran alters the ability of the RanBP3-Crm1 com-
plex to interact with NPCs (see Discussion).
The Crm1–RanBP3–NES–Ran:GTP Complex Is 
Disassembled by RanBP1 and RanGAP
Upon translocation to the cytoplasm, Ran:GTP within the
Crm1–RanBP3-NES-Ran:GTP complex must be removed
to release NES cargo. What factors mediate this event? It
is clear that RanGAP alone is insufficient to mediate dis-
assembly of either the Crm1–Ran:GTP-NES complex
(Askjaer et al., 1999) or the Crm1–RanBP3–NES–Ran:
GTP complex (Fig. 4). Since RanBP1 has been shown to
stimulate export by removing Ran from Crm1–Ran:GTP–
NES complexes and subsequent presentation to RanGAP
(Askjaer et al., 1999; Kehlenbach et al., 1999), we asked
whether it might have a similar role for the Crm1–
RanBP3–NES–Ran:GTP complex.
Figure 6. RanBP3 exports from the nucleus in a Crm1-depen-
dent manner. (A) Triple HA-tagged RanBP3 (HA3-RanBP3) was
transiently expressed in BHK21 cells, which were trypsinized and
replated with an equal number of GSN2 cells and then fused by
addition of polyethyleneglycol. Cells were fixed and stained with
anti-HA Texas red–conjugated secondary antibodies. Nuclei were
identified by DAPI staining. (B) BHK21 cells were cotransfected
with vectors encoding HA3-RanBP3 and GGRanBP1 before cell–
cell fusion. Cells were incubated with LMB (200 nM) after fusion,
or before and after fusion, or with no LMB. After 1 h, cells were
prepared as described above. Bars, 5  m.Lindsay et al. RanBP3 Is a Crm1-dependent Export Factor 1399
To test this hypothesis, RanGAP was added to preas-
sembled export complexes with or without RanBP1.
RanBP1 and RanGAP, but not RanGAP alone, were able
to hydrolyze Ran:GTP bound within both the Crm1–Ran:
GTP–NES complex as well as the Crm1–RanBP3–NES–
Ran:GTP quaternary complex (Fig. 8 A).
What is the mechanism by which RanBP1 disassembles
the quaternary complex? The RBDs of RanBP1 and
RanBP3 are related structurally, and it is likely that
RanBP1 would compete with the RBD of RanBP3 within
the complex to gain access to Ran:GTP. To test this idea,
glutathione–Sepharose beads coated with GST–RanBP3
were incubated with excess Crm1, RanQ69L, and NES
peptide (Fig. 8 B). Under these conditions, no detectable
RanQ69L is able to bind RanBP3 in the absence of Crm1
(data not shown). After complex assembly, the beads were
washed then resuspended in either buffer alone or buffer
containing RanBP1 (1  M), and the bound and unbound
fractions were analyzed at 1 and 10 min. At 1 min, a
slightly greater amount of Crm1 was released from the
beads in the presence of RanBP1 (ratio bound/total   0.59
vs. 0.52). At 10 min the difference was greater, with the ra-
tio decreasing from 0.52 to 0.39. The effect of RanBP1 on
the release of Ran from this complex was more pro-
nounced. At 10 min,  90% of the RanQ69L was released
with RanBP1, whereas in contrast only  50% was re-
leased without RanBP1. These results indicate that
RanBP1 can remove Ran:GTP from the Crm1–RanBP3-
NES-Ran:GTP quaternary complex.
Discussion
In this study we have shown that RanBP3 is a cofactor for
Crm1-mediated nuclear protein export. RanBP3 binds di-
rectly and specifically to Crm1. RanBP3 binding increases
the affinity of the Crm1–RanBP3 complex for Ran:GTP
Figure 7. The Crm1–RanBP3–
NES–Ran:GTP complex inter-
acts with the NPC. (A) Crm1
immunoprecipitations were
performed in the presence or
absence of excess RanBP3.
4     108 digitonin-permeabi-
lized HeLa cells were solubi-
lized, after which the indi-
cated transport factors were
added, incubated for 1 h at
4 C, and precipitated with
anti-Crm antibody and pro-
tein A–Sepharose for 1 h.
After washing 4  in solubili-
zation buffer, bead associ-
ated proteins were immuno-
blotted with RL-1 antibody
(Nup214) or anti-p62 anti-
body. (B) The assay in C was
repeated using GST-RanBP3
to precipitate Crm1. (C)
NPC binding assays. Crm1-
H6 (40 nM) and/or GST-
RanBP3 (400 nM) were
overlayed onto digitonin-
permeabilized BHK21 cells
with either RanQ69L (2
 M), MVM-NS2 NES pep-
tide (4  M), or LMB (2  M)
at 24 C for 30 min. Crm1 and
RanBP3 were identified by
indirect immunofluores-
cence. Bar, 20  m. (D)
Quantitation of Crm1 nu-
clear fluorescence shown in
C. Data represent 50–60 nu-
clei per sample   1 SEM. (E)
Crm1 binding to RanBP3 in
the presence of Ran:GTP. Crm1 (500 nM) was incubated with GST-RanBP3, GST-F, or GST-R on glutathione–Sepharose   RanQ69L
(2  M) and MVM NS2 NES peptide (4  M), as shown, and bound or unbound proteins were immunoblotted.The Journal of Cell Biology, Volume 153, 2001 1400
and NES. RanBP3 possesses three domains: an NH2-ter-
minal region, N, that contains a NLS (Welch et al., 1999);
an F domain that contains two FxFG nucleoporin-like mo-
tifs; and an R domain that is similar to the RBD of
RanBP1. We found that the N and F domains each possess
direct binding sites for Crm1 but that the F and R domains
are both required for full export activity. Additionally, we
found that RanBP3 is a shuttling protein and that its ex-
port is inhibited by the Crm1-specific inhibitor, LMB. The
Crm1–RanBP3 complex exhibits Ran:GTP-dependent in-
teractions with nucleoporins and with the NPC. Finally,
we have shown that the Crm1–RanBP3–NES–Ran:GTP
quaternary complex can be disassembled by the action of
RanBP1 and RanGAP.
Based on these data, we propose a working model for
the facilitation of nuclear protein export by RanBP3 (Fig.
9). In this model, RanBP3 interacts with nuclear Crm1 and
Ran:GTP to facilitate cargo loading. The RBD of RanBP3
stabilizes the interaction of Crm1 with Ran:GTP, which
cooperatively increases the affinity of Crm1 for NES-con-
taining cargo and for the NPC. The association of Ran and
NES with Crm1 induces a conformational switch, altering
the binding mode to RanBP3. The switch reduces interac-
tion of Crm1 with the F domain, but binding through the N
domain of RanBP3 prevents complex disassembly. Addi-
tionally, Ran:GTP mediates an interaction between Crm1
and the R domain of RanBP3. The conformational switch
in Crm1 also exposes a nucleoporin-binding site. We spec-
ulate that the F domain may obscure this site in the ab-
sence of Ran:GTP and cargo, thereby reducing binding to
the NPC. We suggest that the quaternary export complex
translocates through the pore by a facilitated diffusive pro-
cess that requires the low affinity transient association of
Crm1 with nucleoporin FxFG repeats (Ribbeck and Gor-
lich, 2001). On the cytoplasmic side of the NPC, RanBP1
liberates Ran:GTP and presents Ran:GTP to RanGAP.
This terminal step may be promoted by another cofactor,
Nxt1, which appears to facilitate the release of Crm1 and
cargo from the NPC (Black et al., 2001). RanBP3 and
Crm1 can then return to the nucleus. It will be of interest
to determine whether in fact RanBP3 either facilitates the
reimport of Crm1 via the importin  /  pathway, or
whether Crm1 can facilitate the reimport of RanBP3. Ei-
ther or both mechanisms seem plausible, unless there is an
efficient mechanism in the cytosol to ensure dissociation
of the RanBP3–Crm1 complex.
The model predicts that RanBP3 reduces the association
of Crm1with the NPC. Crm1 alone does show detectable
binding to NPCs, which is inhibited by RanBP3 (Fig. 7 C).
However, binding of Crm1 to solubilized nucleoporins in
vitro (Fig. 7 A) was not detectable either in the presence or
absence of RanBP3. This difference may be a result of the
dilution of nucleoporins during solubilization, to interfer-
ence by the detergent, to the existence of Crm1 binding
sites not detected by the RL-1 antibody, or to loss of higher
order structures. Dilution or detergent interference are
perhaps unlikely because we have been unable to detect
significant binding of Crm1 to recombinant nucleoporin
p62 in the absence of this detergent (and of Ran:GTP) in
bead binding assays. At present, therefore, we consider it
likely that NPCs possess Crm1 binding sites in addition to
Nup214 and p62 that are not detectable by the RL-1 anti-
body, or that there are sites destroyed by solubilization.
The RBD of RanBP3 is related to those of RanBP1 and
RanBP2–Nup358 (Mueller et al., 1998), and the ability
to potentiate Crm1-mediated RanGAP protection was,
therefore, unexpected. In fact, these two RBDs have simi-
lar activities in isolation (Beddow et al., 1995; Bischoff et
al., 1995; and Fig. 4 A), but have opposing activities in
the context of karyopherin family members. Although
RanBP1 stimulates the RanGAP-mediated hydrolysis of
Ran:GTP in complex with Crm1, RanBP3 has the reverse
effect and substantially inhibits RanGAP activity towards
a Crm1–RanBP3–Ran:GTP ternary complex. This effect
depends, however, on the relative concentrations of the
RanBP3 and Crm1. When present at a large molar excess,
Figure 8. The Crm1–RanBP3–NES–Ran:GTP complex is dis-
sembled by RanBP1 and RanGAP. (A) GST-RanGAP (30 nM)
or GST-RanGAP plus RanBP1 (1.0  M) were added to com-
plexes of Ran [32P]GTP (40 nM), GST-RanBP3 (1.0  M), Crm1-
H6 (330 nM), and MVM-NS2 NES peptide (200 nM). After 4 min
at 34 C, samples were bound to nitrocellulose filters and washed.
Filter-bound Ran [32P]GTP was detected by scintillation count-
ing. (B) Glutathione–Sepharose beads loaded with GST-
RanBP3, Crm1-H6, RanQ69L, and MVM-NS2 NES peptide,
were aliquoted and resuspended in either buffer or buffer con-
taining RanBP1 (1.0  M). Samples of bound and unbound pro-
teins were analyzed by immunoblotting.Lindsay et al. RanBP3 Is a Crm1-dependent Export Factor 1401
free RanBP3 will compete with the Crm1–RanBP3 com-
plex for Ran:GTP and will stimulate RanGAP activity.
We have observed this behavior in RanGAP assays (data
not shown) and binding assays, and it may explain the
finding that overexpression of the RanBP3 related pro-
tein, Yrb2p, is toxic to yeast (Taura et al., 1997).
Our data are also consistent with other studies of YRB2
function. Although XPO1 is an essential gene in yeast,
strains containing a null allele of YRB2 are viable, suggest-
ing that Yrb2p, like RanBP3, facilitates, but is not neces-
sary for Xpo1p–Crm1p-dependent nuclear protein export
(Taura et al., 1998; Noguchi et al., 1999). The forced over-
expression of Gsp1p (yeast Ran) or Xpo1p suppresses the
cold sensitivity of the yrb2  null mutant (Noguchi et al.,
1999), suggesting that an increase in the nuclear concentra-
tion of either of these proteins can drive the formation of a
competent export complex even in the absence of Yrb2p.
Finally, the recent discovery of new cofactors for Crm1-
mediated export—Nxt1, eIF5A, and RanBP3—exemplify
the complexity of nuclear transport mechanisms and sug-
gest that the search for cofactors involved in other nucleo-
cytoplasmic transport systems may be a fruitful avenue of
research.
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